Navigation Links
Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD

Phase III clinical trial may commence shortly

CARMIEL, Israel, April 18, 2007 /PRNewswire-FirstCall/ --- Protalix BioTherapeutics, Inc. today announced that it has received written notice from the United States Food and Drug Administration (FDA) that it may initiate a Phase III clinical trial in the United States of its lead product candidate, prGCD, a proprietary plant cell expressed recombinant form of human Glucocerebrosidase (GCD), for the treatment of Gaucher Disease, a lysosomal storage disorder in humans.

The FDA has allowed the Company to directly initiate Phase III based upon the results of the Company's pre clinical and Phase I clinical trials of prGCD. The Company presented the completed data from its Phase I clinical trial at the European Working Group of Gaucher Disease (WEGGD) in Cambridge, United Kingdom in July 2006.

The Company hopes to commence the Phase III clinical trial shortly. The trial will take place in centers in the United States, Israel, where approval from the Israeli Ministry of Health has been received, and other locations worldwide. The study will initially consist of male and female adult patients with Gaucher Disease.

David Aviezer, Ph.D., President and Chief Executive Officer of Protalix BioTherapeutics, commented, "The receipt of the FDA's approval to initiate a Phase III clinical trial of prGCD represents an important milestone in the development of this product, and we are excited about the progress we have made thus far. Following the success of our Phase I trial and our promising pre clinical and biochemical data, we believe that we will continue to see positive results from our patients in Phase III."

Dr. Aviezer continued, "We remain deeply committed to the development of a treatment for Gaucher Disease and are excited by the opportunity to commence the Phase III trial and working with the medical experts and patient community."

About
'"/>




Page: 1 2 3

Related medicine technology :

1. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
2. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
3. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
4. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
5. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General Hospital ... AMGN ) announced today that they have ... validate new therapeutic targets and develop novel therapies ... that affects millions worldwide. The MGH-Broad-Amgen collaboration brings ...
(Date:1/15/2014)...  Manufacturers, suppliers and distributors of innovative medical-related products ... most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the Medical ... most litigious industry sectors of cases involving IP ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2
... our ability to target experimental cancer treatments ... hand, and more are on the way ... drugs, MILAN, Italy, April 27 , At today,s ... Meeting,of the European Association for the Study of the Liver ...
... Virology Translate Into New Promising Drugs to Combat Hepatitis ... ... Stem Cells of Potential Benefit in Liver ... Liver Diseases, At today,s sessions of the 43rd Annual Meeting of the European,Association ...
Cached Medicine Technology:Molecular Discoveries Shed Light on Liver Cancer -- Hepatocellular Carcinoma (HCC) 2Molecular Discoveries Shed Light on Liver Cancer -- Hepatocellular Carcinoma (HCC) 3Basic Science Discoveries Yield Progress in Hepatology 2Basic Science Discoveries Yield Progress in Hepatology 3Basic Science Discoveries Yield Progress in Hepatology 4
(Date:7/11/2014)... Cruciate Ligament (ACL) reconstructions occur more than 200,000 times ... create a new ligament may determine how long you ... today at the Annual Meeting of the American Orthopaedic ... study results highlight that in a young athletic population, ... than using autografts (tissue harvested from the patient)," said ...
(Date:7/11/2014)... TX (PRWEB) July 11, 2014 With ... users’ higher requirements on comfort, the installation rate of ... In 2013, the installation rate exceeded 88% and the ... year. In the next few years, Chinese car electric ... 10%; in 2017, the market size is expected to ...
(Date:7/11/2014)... Avery Ranch announced their new website ... more about their services online. Customers can now visit ... home videos online, their featured properties, and the services ... premiere golf course community with 4000+ homes sprawling over ... Ranch features an award winning 18 hole championship golf ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 BellasDress, the ... the most popular online suppliers when it comes to ... unveiled its new collection of beach wedding outfits in ... various kinds of elegant outfits. , BellasDress has ... in the world. According to the company’s senior spokesman, ...
(Date:7/11/2014)... 11, 2014 On Tuesday, July 9, ... Annandale, VA office joined CBS affiliate WUSA’s Andrea ... educate the audience about the number of ways Shady ... motherhood possible for women after they undergo ... treat patients in the developing field known as oncofertility ...
Breaking Medicine News(10 mins):Health News:ACL reconstructions may last longer with autografts 2Health News:China Car Electric Window Regulator Industry to Grow at CAGR of 10% to 2017 Says a New Research Report at ChinaMarketResearchReports.com 2Health News:China Car Electric Window Regulator Industry to Grow at CAGR of 10% to 2017 Says a New Research Report at ChinaMarketResearchReports.com 3Health News:China Car Electric Window Regulator Industry to Grow at CAGR of 10% to 2017 Says a New Research Report at ChinaMarketResearchReports.com 4Health News:Avery Ranch Announces Their New Website to Better Connect with Customers 2Health News:BellasDress Emerges As Popular Online Supplier Of 2014 Beach Wedding Dresses 2Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 2Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 3Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 4
... are more likely to be advertised in magazines with ... adults, resulting in disproportionately high youth exposure to such ... Researchers at the Boston University School of Public Health, ... Media Resources who conducted the study -- published ...
... LAKE CITYHow do fruit flies get high cholesterol and become ... a diet that,s too rich in fats. More importantly, ... Utah human geneticist, fruit flies use the same molecular mechanisms ... a key form of stored fat that contributes to obesity. ...
... 2 Holly Potter, vice president, Public Relations, National Media ... Leader" award at PR News, PR People luncheon ... PR News, PR People Awards competition showcases the top ... making communications matter in the marketplace. The winners of this ...
... , American Red Cross ... , WASHINGTON, Dec. 2 The Hewlett-Packard Company Foundation has ... American Red Cross disaster response. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ... help Philippine communities affected by typhoons in September and October. ...
... , BELLEVUE, Wash., Dec. 2 drugstore.com, ... health, beauty, vision and pharmacy products in the United States, ... plus 50 additional countries worldwide. More than 3.5 billion international ... on http://international.drugstore.com with pricing in their local currency. ...
... is not advised, expert says , WEDNESDAY, Dec. ... to protect their heart might be helping their eyes ... researchers found what they described as a modest benefit ... eye disease that destroys sharp, central vision. , "The ...
Cached Medicine News:Health News:Alcohol companies target youths with magazine ads, new study shows 2Health News:Latest epidemic? High cholesterol, obesity in fruit flies 2Health News:Latest epidemic? High cholesterol, obesity in fruit flies 3Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 3Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 2Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 3Health News:drugstore.com Continues Global Sales Expansion to More Than 3.5 Billion International Consumers 2Health News:In Women, Aspirin Might Ward Off Eye Trouble 2
... the Prostate Specific Antigen (total PSA) test, has ... manage patients with prostate cancer. Of the different ... was the first approved for the detection of ... rectal examination (DRE) in men aged 50 years ...
Stereo Smile II also includes a blank card and tests,at 60, 120, 240 and 480 sec of arc., ,Smile Test II Includes:, 1 demonstration card, 1 pair pediatric 3-D viewers, 1 pair infant 3-D v...
... Smile Tests at 480 and 120 sec ... children of 6,months to 5 years of ... Smile Tests screen for:, Amblyopia, Strabismus, Significant ... Includes:, 1 demonstration card, 1 pair pediatric ...
... Test and Evaluate Random Dot ... (2500 to 1200 sec of arc) ... Includes:, Graded Circle Test (800 to ... Test for Children (400 to 100 ...
Medicine Products: